Alpha Tau Medical Ltd. (DRTSW) NASDAQ
1.85
-0.5(-21.28%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.85
-0.5(-21.28%)
Currency In USD
Sector
Healthcare
Industry
Biotechnology
Employees
125
First IPO Date
March 08, 2022
| Name | Title | Pay | Year Born |
| Uzi Sofer | Chief Executive Officer & Chairman | 1.26M | 1970 |
| Amnon Gat | Chief Operations Officer | 251,000 | 1975 |
| Ronen Segal | Chief Technology Officer | 435,000 | 1973 |
| Robert Den | Chief Medical Officer & Member of Scientific Advisory Board | 756,000 | 1979 |
| Raphi Levy | Chief Financial Officer | 763,000 | 1985 |
| Yael Zeiger | Corporate Controller | 0 | 1983 |
| Rebecca Becker | Vice President of legal | 0 | N/A |
| Yona Keisari | Chief Scientific Officer & Member of Scientific Advisory board | 0 | 1947 |
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, lung, and prostate cancers. The company was founded in 2015 and is headquartered in Jerusalem, Israel.